GB2143238A - A method for enzyme liberation from bacterial cells - Google Patents
A method for enzyme liberation from bacterial cells Download PDFInfo
- Publication number
- GB2143238A GB2143238A GB08308903A GB8308903A GB2143238A GB 2143238 A GB2143238 A GB 2143238A GB 08308903 A GB08308903 A GB 08308903A GB 8308903 A GB8308903 A GB 8308903A GB 2143238 A GB2143238 A GB 2143238A
- Authority
- GB
- United Kingdom
- Prior art keywords
- bacterial cells
- cells
- temperature
- lysis
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The use of a temperature sensitive prophage to procure the lysis of bacterial cells increases the yield of protein available by avoiding the use of harsh or vigorous physical and chemical treatments and by causing the lysis of all the cells in the culture. The lytic process is induced by raising the temperature of the culture to a point at which the prophage becomes unstable but which still allows bacterial metabolism to continue. The method can be applied not only to batch grown cells but also to cells grown in continuous culture.
Description
SPECIFICATION
A novel method for enzyme liberation from bacterial cells
Traditional methods for the rupture of bacterial cells suffer from the disadvantages that the cells must usually be concentrated and cell breakage is often incomplete so that enzyme yield is less than that theoretically possible.
The induction of lysogenic bacteria involves less (if any) cell concentration and there is
100% cell lysis so that enzyme yield can be much higher.
The introduction of a temperature sensitive bacteriophage, e.g. At1857 into a suitable strain of Escherichia coli makes it possible to bring about the induction of the bacteriophage and hence rupture of the bacterial cells by raising the temperature of incubation for a short period.
In a typical example, a lysogenic strain of E.
coli is cultured at 30"C to the appropriate point in the growth cycle for maximum enzyme production. The cells are harvested and resuspended in growth medium, re-incubated for approximately 1 hr at 30"C and then the temperature raised to 42"C for 30 mins followed by a further period of 2-3 hrs at 30"C to allow complete lysis of the cells and enzyme liberation.
The technique will be eminently suitable for application in a continous process whereby growing the cells at sufficient density would obviate the need for the harvesting/resuspension phase and allow direct induction on a continuous basis.
1. The use of a temperature sensitive prophage (or appropriate portion of the genome thereof) to procure the lysis of bacterial cells from within by raising the temperature of incubation, allowing the release of enzymes and other proteins into the suspending liquid.
2. The bacterial cells referred to in Claim 1 are grown in suitable culture medium until the most appropriate stage is reached for release of the desired enzyme or other protein.
3. The bacterial cells referred to in Claim 1 can be grown in continuous culture and being withdrawn continuously are subjected to a higher temperature for a suitable length of time to initiate lysis of the bacterial cells.
4. The bacterial cells referred to in Claim 3 as having been subjected to a higher temperature may be returned to a lower temperature to allow the development of lysis of the bacterial cells.
**WARNING** end of DESC field may overlap start of CLMS **.
Claims (4)
1. The use of a temperature sensitive prophage (or appropriate portion of the genome thereof) to procure the lysis of bacterial cells from within by raising the temperature of incubation, allowing the release of enzymes and other proteins into the suspending liquid.
2. The bacterial cells referred to in Claim 1 are grown in suitable culture medium until the most appropriate stage is reached for release of the desired enzyme or other protein.
3. The bacterial cells referred to in Claim 1 can be grown in continuous culture and being withdrawn continuously are subjected to a higher temperature for a suitable length of time to initiate lysis of the bacterial cells.
4. The bacterial cells referred to in Claim 3 as having been subjected to a higher temperature may be returned to a lower temperature to allow the development of lysis of the bacterial cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08308903A GB2143238A (en) | 1983-03-31 | 1983-03-31 | A method for enzyme liberation from bacterial cells |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08308903A GB2143238A (en) | 1983-03-31 | 1983-03-31 | A method for enzyme liberation from bacterial cells |
Publications (2)
Publication Number | Publication Date |
---|---|
GB8308903D0 GB8308903D0 (en) | 1983-05-11 |
GB2143238A true GB2143238A (en) | 1985-02-06 |
Family
ID=10540532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08308903A Withdrawn GB2143238A (en) | 1983-03-31 | 1983-03-31 | A method for enzyme liberation from bacterial cells |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2143238A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0215533A2 (en) * | 1985-01-18 | 1987-03-25 | Applied Biosystems, Inc. | A method of extracting nucleic acids from cells |
WO1992001791A1 (en) * | 1990-07-26 | 1992-02-06 | Boehringer Mannheim Gmbh | Method of preparation of vaccines, and the use of the vaccines thus prepared |
WO2000071731A1 (en) * | 1999-05-25 | 2000-11-30 | Phage Biotechnology Corporation | Phage-dependent super-production of biologically active protein and peptides |
WO2002014468A2 (en) * | 2000-08-15 | 2002-02-21 | Phage Biotechnology Corporation | Phage-dependent superproduction of biologically active protein and peptides |
GB2373512A (en) * | 2000-11-15 | 2002-09-25 | Lattice Intellectual Property | A method of killing bacteria |
-
1983
- 1983-03-31 GB GB08308903A patent/GB2143238A/en not_active Withdrawn
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0215533A2 (en) * | 1985-01-18 | 1987-03-25 | Applied Biosystems, Inc. | A method of extracting nucleic acids from cells |
EP0215533A3 (en) * | 1985-01-18 | 1988-06-22 | Applied Biosystems, Inc. | A method of extracting nucleic acids from cells |
WO1992001791A1 (en) * | 1990-07-26 | 1992-02-06 | Boehringer Mannheim Gmbh | Method of preparation of vaccines, and the use of the vaccines thus prepared |
WO2000071731A1 (en) * | 1999-05-25 | 2000-11-30 | Phage Biotechnology Corporation | Phage-dependent super-production of biologically active protein and peptides |
US6268178B1 (en) | 1999-05-25 | 2001-07-31 | Phage Biotechnology Corp. | Phage-dependent super-production of biologically active protein and peptides |
US6794162B2 (en) | 1999-05-25 | 2004-09-21 | Phage Biotechnology Corporation | Phage-dependent super-production of biologically active protein and peptides |
WO2002014468A2 (en) * | 2000-08-15 | 2002-02-21 | Phage Biotechnology Corporation | Phage-dependent superproduction of biologically active protein and peptides |
WO2002014468A3 (en) * | 2000-08-15 | 2002-05-10 | Phage Biotechnology Corp | Phage-dependent superproduction of biologically active protein and peptides |
US6773899B2 (en) | 2000-08-15 | 2004-08-10 | Phage Biotechnology Corporation | Phage-dependent superproduction of biologically active protein and peptides |
KR100761486B1 (en) * | 2000-08-15 | 2007-10-04 | 카디오배스큘러 바이오 떼러퓨틱스, 인크. | Phage-Dependent Superproduction of Biologically Active Protein and Peptides |
GB2373512A (en) * | 2000-11-15 | 2002-09-25 | Lattice Intellectual Property | A method of killing bacteria |
Also Published As
Publication number | Publication date |
---|---|
GB8308903D0 (en) | 1983-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4237224A (en) | Process for producing biologically functional molecular chimeras | |
US4468464A (en) | Biologically functional molecular chimeras | |
ES8602124A1 (en) | Externalization of products of bacteria. | |
US4652525A (en) | Recombinant bacterial plasmids containing the coding sequences of insulin genes | |
BR8807408A (en) | PROCESS FOR CONTINUOUS FERMENTATION OF MEDIA CONTAINING CARBON HYDRATE WITH BACTERIAL ASSISTANCE | |
GB2143238A (en) | A method for enzyme liberation from bacterial cells | |
DE3681738D1 (en) | ||
MX172984B (en) | IMMUNO-STIMULATING AGENT | |
US4403035A (en) | In vitro DNA-Protein viral assembly and gene cloning system | |
US7229792B2 (en) | Method of producing recombinant proteins | |
US4169761A (en) | Process for the cultivation of viruses | |
IL44196A (en) | Immobilized glucose isomerase composition | |
EP0225860A3 (en) | A method to export gene products to the growth medium of gram negative bacteria | |
CA2015046C (en) | Recombinant dna and expression vector | |
US4497730A (en) | Method for obtaining periplasmic proteins from bacterial cells using chloroform | |
US3832284A (en) | Method for manufacture of alpha-galactosidase by microorganisms | |
JPS61181374A (en) | Production of neutral protease | |
US4064011A (en) | Process for producing ECoRI restriction endonuclease with E.coli mutants | |
Janeček | Synthesis of β-galactosidase in Escherichia coli in the presence of phenylalanine analogues | |
US5002877A (en) | Production of plasminogen activator from cells to which lectin is added to the culture medium | |
UA26125A (en) | METHOD OF ISSUE OF GROWING CELL MICROORGHISMS FROM NUTRITIONAL BULL | |
Neubauer et al. | Process for production of ColE 1- and related plasmids. | |
INUKAI et al. | STUDIES ON HEMOLYTIC ESCHERICHIA COLI OF O-139 A CERTAIN FACTOR ESSENTIAL FOR HEMOLYSIN PRODUCTION | |
CA1156166A (en) | Recombinant bacterial plasmids containing the coding sequences of insulin genes | |
CN117886908A (en) | Pear DEFL27 protein and in-vitro expression method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |